CEACAM5 and hilar cholangiocarcinoma: In recent years, tumor markers such as cancer antigen (CA) 19‐9 and carcinoembryonic antigen (CEA) have shown promise for diagnosing and monitoring treatment of hilar cholangiocarcinoma.